What we do Unichem Laboratories Ltd manufactures active pharmaceutical ingredients and formulations, operating globally with a focus on exports and multiple therapeutic divisions. |
Founded in 1,962 |
Market share Strong international presence with 98% exports; part of Ipca Laboratories group with expanding global footprint. |
Problem solved Provides affordable, quality medicines addressing diverse therapeutic needs worldwide, enhancing healthcare accessibility. |
Top clients or who we serve Pharmaceutical companies, healthcare providers worldwide; primarily B2B with expanding formulation sales via subsidiaries. |
Key management Dr. Prakash A. Mody (Chairman), Mr. Pabitrakumar Bhattacharyya (Managing Director), Mr. Sanjay Jain (CFO). |
Our journey and innovations Founded in 1962; multiple expansions in API and formulation plants; strategic international acquisitions and capacity expansions; part of Ipca Group since 2024. |
Where we operate India with manufacturing in Maharashtra, Goa, Uttar Pradesh, Madhya Pradesh, Himachal Pradesh; exports globally including USA, Europe, Africa. |
Top products or what we offer Active pharmaceutical ingredients, generic formulations, specialty divisions including women's health, dermatology, nephrology, and cardiology. |
Top brands - |
Raw materials needed Chemical compounds and intermediates for pharmaceutical synthesis. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue predominantly from recurring sales with long-term export contracts and steady API supply. |
Our industry position Well-established API manufacturer and pharmaceutical exporter; growing EBITDA and market share with strong parent group backing. |
Financial highlights Consolidated Revenue ₹2,111 crores; Profit after tax ₹138 crores; 18.3% revenue growth; margin improved to 58.2%. |
Geographical revenue split Exports dominate with 98% revenue from outside India, mainly USA and Europe; 2% revenue from domestic operations. |
Order book - |
Whats driving growth Capacity expansions, strategic IP acquisition, increased global demand, stronger cost structure, and integration with Ipca Laboratories. |
Our future plans Further capacity expansion, integration with Ipca operations, divestment of non-core assets, and increased focus on international markets. |
Our green promise Significant reduction in greenhouse gas emissions; ongoing energy conservation and sustainable operations initiatives. |
Our people and values Commitment to inclusive, safe workplace; focus on ethical practices, employee well-being, and continuous development. |
Key challenges ahead Managing operational costs, geopolitical risks, regulatory compliances, and maintaining competitive edge in global markets. |
Interesting facts Mumbai-based Unichem is ISO 9001 and ISO 14001 certified with WHO and MHRA-approved manufacturing plants spanning multiple Indian states. |
Risks and strategy Risks include market volatility and competition; mitigated by innovation, diversification, strong governance, and parent company support. |
